ArticleOncotarget2015

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma.

Tiansuo Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.